EP BiocompositesShare price, financial results, shareholding and management
- Market cap
- ₹15 cr
- Stock P/E
- 10.1peers 18.1
- Book value
- ₹71.7
- Price to book
- 1.23
- EV / operating profit
- -
- Market cap to sales
- 1.09
- ROCE · FY26
- 16.3%
- ROE · FY26
- 12.9%
- ROE, 3-year average
- 12.0%
- Operating margin · FY26
- 16.4%peers 16.8%
- Sales growth, 3 years
- 24.1%
- Profit growth, 3 years
- 36.0%
- Debt to equity
- 0.20peers 0.28
- Borrowings
- ₹2.4 cr
- Interest cover
- 6.7×
- Cash from business / op. profit
- 89%
- Debtor days
- 317
- Pledged
- 0.00%
- Promoter holding
- 70.08%
- Change in promoter holding
- 0.00 pts
- Shareholders
- 337
- 52-week high / low
- ₹132 / ₹76
- Dividend yield
- 0.00%
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
newboard is reading this company's filings. Its plain description, key points, management and study will appear here soon; the figures below are worked out from what it has filed.
EP Biocomposites share price chart
Close on 3 Nov 2026 · -2.00% on the day · Vol 3,000
Daily prices to 3 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 3 Nov 2026
- 1 month
- -2.2%
- 3 months
- -20.7%
- 6 months
- -12.0%
- 1 year
- -31.2%
- Traded a day, 20 days
- ₹0.02 cr
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | +14% | +42% |
| 3 years, a year | +24% | +36% |
| Latest half, H2 FY26 | +26% | +67% |
EP Biocomposites revenue and profit growth
Half-yearly results · Profit and lossSales have grown fast. Last year profit grew faster than sales, so the company kept more from each rupee of sales.
SME companies report every six months. In the latest half, sales were higher than in the same half a year before. Profit grew faster than sales.
EP Biocomposites half-yearly results
SME companies report every six months · ₹ crore
| H1FY23 | H2FY23 | H1FY24 | H2FY24 | H1FY25 | H2FY25 | H1FY26 | H2FY26 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 3.45 | 3.68 | 4.40 | 7.04 | 4.41 | 7.60 | 4.08 | 9.56 |
| Expenses | 2.92 | 3.26 | 4.13 | 5.90 | 3.92 | 6.31 | 3.83 | 7.57 |
| Operating profit | 0.53 | 0.42 | 0.27 | 1.14 | 0.49 | 1.29 | 0.24 | 1.99 |
| OPM | 15.3% | 11.4% | 6.1% | 16.2% | 11.1% | 16.9% | 6.0% | 20.8% |
| Interest | 0.15 | 0.05 | 0.01 | 0.02 | 0.17 | 0.19 | 0.15 | 0.19 |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.05 |
| Profit before tax | 0.36 | 0.45 | 0.30 | 1.27 | 0.31 | 1.11 | 0.12 | 1.82 |
| Net profit | 0.27 | 0.31 | 0.22 | 0.93 | 0.21 | 0.82 | 0.09 | 1.37 |
EP Biocomposites profit and loss
Full years to March, FY20 to FY26 · ₹ crore, consolidated where reported
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.57 | 2.95 | 8.06 | 7.13 | 11.44 | 12.01 | 13.64 |
| Expenses | 0.53 | 2.49 | 6.66 | 6.18 | 10.03 | 10.23 | 11.40 |
| Operating profit | 0.04 | 0.46 | 1.40 | 0.95 | 1.41 | 1.78 | 2.24 |
| OPM | 7.0% | 15.6% | 17.4% | 13.3% | 12.3% | 14.8% | 16.4% |
| Other income | 0 | 0 | 0.02 | 0.17 | 0.30 | 0.11 | 0.14 |
| Interest | 0 | 0 | 0.19 | 0.20 | 0.03 | 0.35 | 0.34 |
| Depreciation | 0 | 0 | 0.07 | 0.10 | 0.10 | 0.11 | 0.10 |
| Profit before tax | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 | 1.94 |
| Tax rate | 25.0% | 23.9% | 30.2% | 28.4% | 26.8% | 27.5% | 24.7% |
| Net profit | 0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | 1.46 |
| EPS ₹ | 6 | 72 | 6.88 | 3.94 | 6.84 | 6.13 | · |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Earnings per share is left blank where the source shows zero against a profit.
Earnings per share before FY21 is on the share count of that time, before later bonus or share issues, so it does not compare with the years after.
EP Biocomposites profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. It earns a moderate return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Operating margin | 7.0% | 15.6% | 17.4% | 13.3% | 12.3% | 14.8% | 16.4% |
| Tax rate | 25.0% | 23.9% | 30.2% | 28.4% | 26.8% | 27.5% | 24.7% |
| ROCE | · | 219.0% | 41.5% | 12.8% | 15.2% | 14.2% | 16.3% |
| ROE | · | 171.4% | 67.8% | 11.1% | 12.8% | 10.2% | 12.9% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
EP Biocomposites debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has grown. Its loans are smaller than its own money. Last year the business brought in more cash than it showed as profit. Customers take about as long to pay as they did in FY24.
Bars below the line are cash going out.
EP Biocomposites balance sheet
At each 31 March · ₹ crore
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 | 1.68 |
| Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 | 10.37 |
| Net worth | 0.03 | 0.39 | 2 | 8.41 | 9.56 | 10.59 | 12.05 |
| Borrowings | 0 | 0 | 4.11 | 1.28 | 1.80 | 2.98 | 2.39 |
| Other liabilities | 0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | 4.30 |
| Total liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 18.74 |
| Fixed assets | 0 | 0 | 0.41 | 0.33 | 0.33 | 0.23 | 0.24 |
| Capital work in progress | 0 | 0 | 0 | 0 | 0.14 | 0.14 | 0.62 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | 17.88 |
EP Biocomposites cash flow
₹ crore
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | 0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | 1.99 |
| Cash from investing | 0 | 0 | -0.47 | 0.02 | -0.16 | 0.02 | -0.53 |
| Cash from financing | 0 | 0 | 4.76 | 2.81 | 0.49 | 0.82 | -0.92 |
| Net cash flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.91 | 0.35 | 0.54 |
Working capital
Days
| FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 192 | 80 | 322 | 300 | 287 | 330 | 317 |
| Inventory days | 84 | 90 | 87 | 91 | 50 | 67 | 57 |
| Days payable | 350 | 128 | 162 | 105 | 143 | 98 | 114 |
| Cash conversion cycle | -74 | 42 | 246 | 286 | 194 | 299 | 260 |
| Working capital days | -58 | 26 | 157 | 256 | 217 | 271 | 237 |
EP Biocomposites peers and competitors
Listed SME companies in the same industryBy sales, EP Biocomposites is number 15 of the 15 listed SME companies in other utilities.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Urban Enviro Waste Management | 106 | 7.2 | 182 | 14.9 | 17.4% | 0.72 |
| Z-Tech (India) | 733 | 20.3 | 156 | 36 | 28.0% | 0.34 |
| Apex Ecotech | 336 | 19.8 | 149 | 17 | 14.6% | 0.02 |
| Sattva Engineering Construction | 102 | 7.8 | 143 | 13.1 | 15.4% | 0.34 |
| Hi-Green Carbon | 344 | 100.4 | 139 | 3.4 | 16.7% | 0.70 |
| Organic Recycling Systems | 214 | 8.6 | 105 | 25 | 29.0% | 0.37 |
| Felix Industries | 330 | 18.2 | 102 | 18.1 | 27.6% | 0.22 |
| GEM Enviro Management | 90 | 18.0 | 101 | 5 | 5.0% | 0.09 |
| Filtra Consultants and Engineers | 71 | 18.9 | 97.7 | 3.7 | 4.8% | 0.05 |
| Greenleaf Envirotech | 76 | 10.5 | 60.6 | 7.2 | 16.9% | 0.19 |
| EP Biocomposites | 15 | 10.1 | 13.6 | 1.5 | 16.4% | 0.20 |
| Median of the 10 others | 160 | 18.1 | 122 | 14 | 16.8% | 0.28 |
EP Biocomposites shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own more than half the company. Big foreign and Indian funds own very little. The number of shareholders is about the same.
EP Biocomposites shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.08% | 70.08% | 70.08% | 70.08% | 70.05% | 70.08% | 70.08% | 70.08% |
| Foreign investors (FIIs) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | - |
| Number of shareholders | 365 | 365 | 382 | 374 | 361 | 356 | 353 | 337 |
EP Biocomposites latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- H2 FY26: sales ₹9.6 cr (+26%), net profit ₹1.4 cr (+67%) on H2 FY25.
- Shareholding, 30 June 2026: promoters unchanged at 70.08%.
- 26 Sept 2026: an order announced.
EP Biocomposites announcements
7 on record, latest first; each opens the filing on the exchange
- AGM/EGMScrutinizer''s Report for the 7th Annual General MeetingPDF ↗
- Company UpdateIntimation of Strategic Collaboration and Consultancy Agreement entered with Malligavad Foundation and Anand MalligavadPDF ↗
- Insider Trading / SASTClosure of trading window till the publication of half yearly results of the CompanyPDF ↗
- AGM/EGMProceedings of the seventh annual general meeting of the CompanyPDF ↗
- Company UpdateIntimation for award of order for 70KLD STP unitPDF ↗
- AGM/EGMChairman''s speech proposed to be delivered in the upcoming annual general meetingPDF ↗
- Company UpdatePresentation prepared for the upcoming annual general meeting and upcoming investor meet, if anyPDF ↗
EP Biocomposites annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
EP Biocomposites share split, bonus and dividends
From the corporate actions the company announces on the exchange
No share split, bonus issue or dividend is on record since listing.
Checks we ran on EP Biocomposites' data · 9
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- iThe shares traded on only 119 days in the past year, so the price, its range and the returns here rest on few trades.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (16,81,500 shares).
- ✓The share capital in the FY26 results matches the share count in the shareholding pattern.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- ✓The two half-years of FY26 add up to the full-year sales.
- !Earnings per share changes basis between FY21 (₹72.00) and FY22 (₹6.88) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
- ✓Revenue and profit are reported for every year shown, FY20 to FY26.
- iPrices run to the close on 6 Oct 2026, from the exchange's daily figures.
Questions people ask about EP Biocomposites
What does EP Biocomposites do?
EP Biocomposites is an SME company listed on BSE SME, in other utilities.
What is the share price of EP Biocomposites?
₹88 at the close on 3 Nov 2026, from the exchange's daily figures.
What is the market cap of EP Biocomposites?
₹15 cr at the close on 3 Nov 2026, on 16,81,500 shares.
What is the P/E of EP Biocomposites?
10.1 times FY26 profit at the close on 3 Nov 2026 (our arithmetic).
What are EP Biocomposites' revenue and profit?
Revenue ₹14 cr and profit after tax ₹1 cr in FY26.
Who are the promoters of EP Biocomposites?
The promoter group; promoters held 70.08% at 30 June 2026.
What is EP Biocomposites' website?
www.epbiocomposites.com
More SME companies like EP Biocomposites
Other listed SME companies in other utilities, the closest in size first, each read from its own documents.
- Greenleaf EnvirotechGREENLEAF · NSE Emerge · Other Utilities · listed 2025Market cap ₹59 cr
- Filtra Consultants and EngineersFILTRA · BSE SME · Other UtilitiesMarket cap ₹69 cr
- Urban Enviro Waste ManagementURBAN · NSE Emerge · Other Utilities · listed 2023Market cap ₹79 cr
- GEM Enviro ManagementGEMENVIRO · BSE SME · Other UtilitiesMarket cap ₹86 cr
- Sattva Engineering ConstructionSATTVAENGG · NSE Emerge · Other Utilities · listed 2025Market cap ₹89 cr
- Felix IndustriesFELIX · NSE Emerge · Other Utilities · listed 2017Market cap ₹313 cr
Built from 7 exchange announcements, 8 shareholding patterns and 7 years of reported results. Every figure carries its source; where the documents are silent, the page says so.